GE HealthCare Technologies Inc. $GEHC Shares Acquired by Nordea Investment Management AB

Nordea Investment Management AB boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 564.4% in the 4th quarter, Holdings Channel reports. The firm owned 284,344 shares of the company’s stock after buying an additional 241,548 shares during the period. Nordea Investment Management AB’s holdings in GE HealthCare Technologies were worth $23,515,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Wedge Capital Management L L P NC bought a new position in shares of GE HealthCare Technologies in the third quarter valued at $26,859,000. Valicenti Advisory Services Inc. boosted its stake in shares of GE HealthCare Technologies by 22.6% during the 3rd quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock worth $5,115,000 after acquiring an additional 12,550 shares in the last quarter. Temasek Holdings Private Ltd acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter worth $99,922,000. Locust Wood Capital Advisers LLC grew its holdings in shares of GE HealthCare Technologies by 7.1% in the 3rd quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock worth $156,534,000 after acquiring an additional 137,992 shares during the last quarter. Finally, Nan Fung Trinity HK Ltd. acquired a new stake in shares of GE HealthCare Technologies during the third quarter worth $23,206,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 1.0%

NASDAQ:GEHC opened at $70.96 on Wednesday. The stock has a market cap of $32.38 billion, a PE ratio of 15.56, a price-to-earnings-growth ratio of 1.57 and a beta of 1.03. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $89.77. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The stock’s 50-day moving average is $78.64 and its two-hundred day moving average is $78.42.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period last year, the company posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.07%.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on GEHC. Jefferies Financial Group upped their target price on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a report on Thursday, December 11th. The Goldman Sachs Group restated a “buy” rating and set a $98.00 price objective on shares of GE HealthCare Technologies in a report on Friday, January 9th. Piper Sandler upped their price objective on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, January 30th. BTIG Research reiterated a “buy” rating and issued a $91.00 target price on shares of GE HealthCare Technologies in a report on Thursday, March 19th. Finally, Citigroup dropped their target price on shares of GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 11th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $92.17.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.